Vemurafenib 240 mg in India

About Medicine

  • Brand Name: Zelboraf
  • API: Vemurafenib
  • Packaging: 10 tablets in 1 strip
  • Strength: 240 mg
  • Manufacturer Name: Roche Products India Pvt Ltd
Get Price


Vemurafenib Uses:

VEMURAFENIB (Zelboraf 240 mg) Tablet is used for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation.

Dosage: The recommended dose of Zelboraf is 960 mg (four 240 mg tablets) orally every 12 hours with or without a meal. A missed dose of vemurafenib can be taken up to four hours prior to the next dose. Treat patients with vemurafenib until the disease is progressive or unacceptable toxicity occurs. Do not take an additional Zelboraf dose if vomiting occurs after administration, but continue with the next scheduled dose. It is not recommended to crush or chew the vemurafenib tablets.

Side Effects: The most commonly reported vemurafenib side effects include:

  • Arthralgia
  • Rash
  • Alopecia
  • Fatigue
  • Nausea
  • Pruritus
  • Skin papilloma
  • Photosensitivity reaction

Warnings and Precautions:

  • Perform dermatologic evaluations before initiating therapy and every two months while on therapy.
  • Monitor patients receiving Zelboraf 240 mg closely for signs or symptoms of other malignancies.
  • Permanently discontinue Zelboraf in patients who develop a severe hypersensitivity reaction.
  • Monitor alkaline phosphatase, transaminases and bilirubin before initiation of therapy and monthly during treatment.
  • The Zelboraf 240 mg can cause fetal harm in case administered to a pregnant woman. Advise pregnant women of the potential risk to a fetus.
  • Monitor patients closely when Zelboraf is used concomitantly or sequentially with radiation treatment.
  • Measure serum creatinine prior to thr initiation of Zelboraf and periodically during treatment.

More info

Storage: Store vemurafenib pills at room temperature between 68°F to 77°F (20°C to 25°C). Store it in the original container with the lid tightly closed. Keep vemurafenib pills and all medication out of the reach of children.

Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the VEMURAFENIB at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the VEMURAFENIB Tablets.

Buying Procedure: In order to buy VEMURAFENIB, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp +919310090915 or an Email to us at: along with the legitimate ID Proof, standard Prescription and Medical Reports.

Conclusion: Vemurafenib demonstrated the improved rates of OS (overall survival) and PFS (progression-free survival) in recipients with previously untreated melanoma with the BRAF V600E mutation.



Vemurafenib is an inhibitor of the B-Raf enzyme developed for the treatment of late-stage melanoma.

How is VEMURAFENIB supplied?

VEMURAFENIB is supplied as tablets of 240mg for oral administration.

In how many countries VEMURAFENIB 240mg is approved for marketing?

VEMURAFENIB is available/approved in USA and Europe. We can help you to access it in India.

How can I get VEMURAFENIB 240mg in India?

VEMURAFENIB is a prescription only drug and is not approved for marketing in India.

The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –

We facilitate by:-

  • Helping in documentation to import the medicine for personal use
  • Finding Genuine and reliable source in USA, Europe and Japan
  • Ensuring 100% transparency.

VEMURAFENIB 240mg can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.

The Indian Pharma can facilitate the supply of VEMURAFENIB (prescription medicine) to all locations in the world and in India after fulfilling the legal requirement.

The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees.

Can I get VEMURAFENIB even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country

The Indian Pharma (IP) can help patients in accessing/importing VEMURAFENIB, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your inquiry to find:-

  • VEMURAFENIB in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong.
  • VEMURAFENIB in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
  • VEMURAFENIB in North America – Mexico.
  • VEMURAFENIB in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
  • VEMURAFENIB in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
  • VEMURAFENIB in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia. VEMURAFENIB in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
  • VEMURAFENIB in Australia and New Zealand.

How do I contact The Indian Pharma?

You can use a different channel to contact The Indian Pharma (TIP). Tele & Mobile: You can reach us on +91 9310090915 or +91-120-4080562. Email: We can also address your enquiries if sent directly to We will respond within 24 hours along with vemurafenib cost/price & procurement details after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working day after receiving your query form.